A 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren 300 mg / Amlodipine 10 mg in Patients With Essential Hypertension
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Aliskiren/amlodipine (Primary) ; Aliskiren/amlodipine/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Adverse reactions
- 21 Jan 2011 New trial record